Medications starting with

The drug is used to reduce elevated intraocular pressure in adults (including the elderly) with open-angle glaucoma, as well as in children with elevated intraocular pressure and pediatric glaucoma.

Dosage form: drops, ophthalmic solution

ATC code: S01EE01

Manufacturer: Pfizer Manufacturing Belgium

The drug is prescribed for adults for the treatment of advanced non-small cell lung cancer (both ALK-positive and ROS1-positive), as well as for children (from 2 to 18 years old) for the treatment of certain types of lymphoma (ALK+ diffuse large B-cell lymphoma) and tumors (anaplastic large cell lymphoma) that are ALK-positive.

Dosage form: capsules

ATC code: L01ED01

Manufacturer: Pfizer Manufacturing Deutschland GmbH

The drug is used for the treatment of adults with advanced non-small cell lung cancer (NSCLC) that is ALK-positive or ROS1-positive. It is also indicated for the treatment of children (aged 6 to 18 years) with certain types of lymphoma (ALCL) or tumors (SMT) that are ALK-positive.

Dosage form: capsules

ATC code: L01ED01

Manufacturer: Pfizer Manufacturing Deutschland GmbH

The drug is used to reduce elevated intraocular pressure in patients with open-angle glaucoma.

Dosage form: drops, ophthalmic solution

ATC code: S01ED51

Manufacturer: LLC "FARMEKS GROUP"

The drug is used to reduce elevated intraocular pressure in patients with open-angle glaucoma, as well as in children with elevated intraocular pressure and pediatric glaucoma.

Dosage form: drops, ophthalmic solution

ATC code: S01EE01

Manufacturer: Taejoon Pharm. Co. Ltd (manufacturing APIs, primary packaging, quality control)

The drug is used to reduce elevated intraocular pressure in patients with open-angle glaucoma if other medications in this class do not provide sufficient effect.

Dosage form: drops, ophthalmic solution

ATC code: S01ED51

Manufacturer: Lomapharm GmbH (manufacturing, packaging, quality control and batch release of medicinal product)

The drug is used to reduce elevated intraocular pressure in adults with open-angle glaucoma, as well as in children with pediatric glaucoma and elevated intraocular pressure.

Dosage form: drops, ophthalmic solution

ATC code: S01EE01

Manufacturer: Lomapharm GmbH (manufacturing, packaging, quality control and batch release of medicinal product)

The drug is used to improve blood sugar control in adults with type 2 diabetes as an adjunct to diet, physical exercise, and other medications.

Dosage form: solution for injection

ATC code: A10AE56

Manufacturer: A/S Novo Nordisk (manufacturer responsible for collection, labeling and secondary packaging of finished product, quality control of finished product; manufacturer of unpackaged product, filling, primary packaging, inspection and quality control, responsible for batch release of final product)

The drug is used for circulatory disorders (cerebral and peripheral), Raynaud's disease, diabetic angiopathy, migraine, Meniere's disease, as well as for retinal vascular problems, thrombosis, embolism, and trophic ulcers.

Dosage form: solution for injection

ATC code: C04AD02

Manufacturer: PJSC "Halychpharm"

The drug is used as part of complex therapy for cerebral and peripheral circulatory disorders, vascular atherosclerosis, Raynaud's disease, Buerger's disease, thrombosis, thrombophlebitis, trophic ulcers, pressure sores, migraine, Meniere's syndrome, as well as for elevated cholesterol and triglyceride levels.

Dosage form: tablets

ATC code: C04AD02

Manufacturer: PJSC "Halychpharm"

The drug is used for the prevention of venous thromboembolism in adults following hip or knee replacement surgery. It is also prescribed for the treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and to prevent their recurrence.

Dosage form: tablets, film-coated

ATC code: B01AF01

Manufacturer: Bayer AG (Production of bulk products, primary packaging, secondary packaging, batch control, batch release)

The drug is used for the prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation. It is also prescribed for the treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and for the prevention of their recurrence. In children, it is used for the treatment and prevention of recurrences of venous thromboembolism (VTE).

Dosage form: tablets, film-coated

ATC code: B01AF01

Manufacturer: Bayer AG (manufacturing bulk products, primary packaging, secondary packaging, batch control, batch release)

The drug is used for the prevention of stroke and systemic embolism in adults with non-valvular atrial fibrillation. It is also prescribed for the treatment of deep vein thrombosis (DVT), pulmonary embolism (PE), and for the prevention of their recurrence. In children, it is used for the treatment and prevention of recurrences of venous thromboembolism (VTE).

Dosage form: tablets, film-coated

ATC code: B01AF01

Manufacturer: Bayer AG (manufacturing bulk products, primary packaging, secondary packaging, batch control, batch release)

The drug is indicated for adults for the prevention of atherothrombotic events following acute coronary syndrome (ACS), as well as for patients with ischemic heart disease or peripheral artery disease with a high risk of ischemic complications.

Dosage form: tablets, film-coated

ATC code: B01AF01

Manufacturer: Bayer AG (for the entire manufacturing process)

The drug is used for the treatment of venous thromboembolism (VTE) and the prevention of its recurrence in children and adolescents (up to 18 years of age) following initial therapy with other anticoagulants.

Dosage form: suspension, oral

ATC code: B01AF01

Manufacturer: Bayer AG (manufacturing in bulk, primary packaging, secondary packaging, quality control, batch release)

The drug is used to alleviate neurological symptoms and functional disorders in acute ischemic stroke, to slow the progression of amyotrophic lateral sclerosis (ALS), and as part of complex treatment for the systemic inflammatory response in coronavirus disease (COVID-19).

Dosage form: solution for injection

ATC code: N07XX14

Manufacturer: Yuria-Pharm LLC

The drug is used for the short-term treatment of mild to moderate acute pain in adults, as well as for the relief of pain and inflammation in osteoarthritis and rheumatoid arthritis.

Dosage form: tablets, film-coated

ATC code: M01AC05

Manufacturer: Takeda GmbH, manufacturing site Oranienburg

The drug is used for the short-term treatment of mild to moderate acute pain in adults, as well as for the relief of pain and inflammation in osteoarthritis and rheumatoid arthritis.

Dosage form: tablets, film-coated

ATC code: M01AC05

Manufacturer: Takeda GmbH, manufacturing site Oranienburg

The drug is used for the short-term symptomatic treatment of acute pain of mild to moderate intensity in adults.

Dosage form: powder for injection solution

ATC code: M01AC05

Manufacturer: Takeda Austria GmbH (secondary packaging and batch release)

The drug is used for the short-term symptomatic treatment of mild to moderate acute pain in adults.

Dosage form: tablets, film-coated

ATC code: M01AC05

Manufacturer: Takeda GmbH, manufacturing site Oranienburg

The drug is used to administer general anesthesia in adults during surgical operations, dental procedures, or gynecological interventions. It is also used for analgesia and to enhance the effect of other anesthetics.

Dosage form: gas, compressed

ATC code: N01AX15

Manufacturer: INGAZ LLC

The drug is prescribed for the treatment of active rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, ulcerative colitis, as well as polyarticular juvenile idiopathic arthritis in children weighing 40 kg or more.

Dosage form: tablets, film-coated

ATC code: L04AF01

Manufacturer: Pfizer Manufacturing Deutschland GmbH (full-cycle manufacturing)

The drug is intended for the treatment of adults with active rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis who have not achieved an adequate response to standard therapy.

Dosage form: tablets, extended-release

ATC code: L04AF01

Manufacturer: Pfizer Manufacturing Deutschland GmbH (testing, packaging, batch release)

The drug is used to treat colon cancer (colorectal cancer), stomach cancer, as well as breast cancer.

Dosage form: tablets, film-coated

ATC code: L01BC06

Manufacturer: Exella GmbH & Co. KG (Manufacturing with full cycle)

The drug is used to treat colon cancer (colorectal cancer), stomach cancer, as well as breast cancer (both local and metastatic).

Dosage form: tablets, film-coated

ATC code: L01BC06

Manufacturer: Exella GmbH & Co. KG (Manufacturing with full cycle)

The drug is used for the treatment of obesity (with a body mass index ≥ 30 kg/m²) or overweight (with a body mass index ≥ 28 kg/m²), particularly in individuals with obesity-related risk factors. It should be used in conjunction with a moderately low-calorie diet.

Dosage form: capsules

ATC code: A08AB01

Manufacturer: Delpharm Milano S.R.L. (manufacturing of unpackaged products, primary and secondary packaging, quality control testing)

The drug is intended for the treatment of adult patients with multiple myeloma. It is used in combination with other medicinal products (bortezomib and dexamethasone or dexamethasone alone) depending on the patient's previous treatment experience.

Dosage form: capsules, hard

ATC code: L04AX06

Manufacturer: Dr. Reddy's Laboratories Ltd, FTO-7

The drug is intended for the treatment of adult patients with multiple myeloma. It is used in combination with other medicinal products (bortezomib and dexamethasone or dexamethasone alone) depending on the patient's previous treatment experience.

Dosage form: capsules, hard

ATC code: L04AX06

Manufacturer: Dr. Reddy's Laboratories Ltd, FTO-7

The drug is intended for the treatment of adult patients with multiple myeloma. It is used in combination with other medicinal products (bortezomib and dexamethasone or dexamethasone alone) depending on the patient's previous treatment experience.

Dosage form: capsules, hard

ATC code: L04AX06

Manufacturer: Dr. Reddy's Laboratories Ltd, FTO-7

The drug is intended for the treatment of adult patients with multiple myeloma. It is used in combination with other medicinal products (bortezomib and dexamethasone or dexamethasone alone) depending on the patient's previous treatment history.

Dosage form: capsules, hard

ATC code: L04AX06

Manufacturer: Dr. Reddy's Laboratories Ltd, FTO-7

The drug is used for enzyme replacement therapy in children and adults with acid sphingomyelinase deficiency (ASM deficiency) type A/B or B, which is not accompanied by central nervous system manifestations.

Dosage form: powder for preparation of concentrate for infusion solution

ATC code: A16AB25

Manufacturer: Genzyme Ireland Limited (manufacturing of the final product (filling, lyophilization), packaging, labeling, quality control and batch release, analytical testing of intermediate and finished medicinal products, stability testing, storage)

The drug is used for the temporary reduction of facial wrinkles (between the eyebrows, around the eyes, and on the forehead) in adults up to 65 years of age. It is also indicated for the treatment of blepharospasm, spasmodic torticollis, and arm muscle spasticity.

Dosage form: powder for injection solution

ATC code: M03AX01

Manufacturer: Merz Pharma GmbH & Co. KGaA (manufacturing of unpackaged product, in-process quality control testing, cell-based quantification, quantitative determination of Botulinum neurotoxin Clostridium Botulinum type A (ELISA), primary packaging; secondary packaging, batch release)

The drug is used for the temporary reduction of facial wrinkles (between the eyebrows, around the eyes, and on the forehead) in adults up to 65 years of age. It is also prescribed for the treatment of blepharospasm, cervical dystonia, and muscle spasticity in the arm.

Dosage form: powder for injection solution

ATC code: M03AX01

Manufacturer: Merz Pharma GmbH & Co. KGaA (manufacturing of unpackaged product, in-process quality control testing, cell-based assay, quantitative determination of Botulinum neurotoxin Clostridium Botulinum type A (ELISA), primary packaging; secondary packaging, batch release)

The drug is used for maintenance therapy of schizophrenia symptoms in adults whose condition has been stabilized with paliperidone or risperidone.

Dosage form: suspension for injection, prolonged action

ATC code: N05AX13

Manufacturer: Janssen Pharmaceutica NV

The drug is used as an antiseptic, astringent, and drying agent for inflammatory skin diseases.

Dosage form: powder, topical

ATC code: D08AX

Manufacturer: Istok-Plus LLC

The drug is used to treat bacterial infections caused by microorganisms sensitive to it. In particular, it is used for severe infections of the throat, nose, and ear (mastoiditis, sinusitis, epiglottitis), exacerbation of chronic bronchitis, pneumonia, urinary tract infections (cystitis, pyelonephritis), infections of the skin, soft tissues, bones, joints, intra-abdominal infections, and infections of the female genital organs. The drug may also be used to prevent infections during major surgeries.

Dosage form: powder for injection solution or infusion solution

ATC code: J01CR02

Manufacturer: ANTIBIOTICS SA

The drug is used to prevent skeletal-related events (such as pathological fractures, the need for bone radiation, surgical intervention on bones, or spinal cord compression) in adults with late-stage malignant tumors that affect the bones. It is also indicated for the treatment of adults and adolescents with mature skeletal systems who have giant cell bone tumors, if they cannot be surgically removed or if surgery poses a risk of severe consequences.

Dosage form: solution for injection

ATC code: M05BX04

Manufacturer: Amgen Manufacturing Limited (manufacturer of unpackaged product, primary packaging)

The drug is used to reduce the recurrence of overt hepatic encephalopathy in adults, as well as for the treatment of irritable bowel syndrome with diarrhea.

Dosage form: tablets, film-coated

ATC code: A07AA11

Manufacturer: Alfasigma S.p.A.

The drug is intended for adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control. It is also used to reduce the risk of hospitalization due to heart failure in patients with established cardiovascular disease or risk factors.

Dosage form: tablets, film-coated, prolonged release

ATC code: A10BD15

Manufacturer: AstraZeneca Pharmaceuticals LP (manufacturing of medicinal product, quality control testing, packaging and release)

The drug is intended for adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control. It also helps to reduce the risk of hospitalization due to heart failure in patients with type 2 diabetes and established cardiovascular disease or risk factors.

Dosage form: tablets, film-coated, prolonged release

ATC code: A10BD15

Manufacturer: AstraZeneca Pharmaceuticals LP (manufacturing of medicinal product, quality control testing, packaging and release)

The drug is intended for adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control. It is also used to reduce the risk of hospitalization due to heart failure in patients with type 2 diabetes and established cardiovascular disease or risk factors.

Dosage form: tablets, film-coated, prolonged release

ATC code: A10BD15

Manufacturer: AstraZeneca Pharmaceuticals LP (manufacturing of medicinal product, quality control testing, packaging and release)

The drug is used to treat rheumatoid arthritis, discoid and systemic lupus erythematosus, as well as certain dermatological diseases that are exacerbated by sunlight. In children, it is prescribed for the treatment of juvenile idiopathic arthritis (in combination with other medications) and lupus erythematosus.

Dosage form: tablets, film-coated

ATC code: P01BA02

Manufacturer: Farmak JSC

The drug is used to treat arterial hypertension (high blood pressure), as well as cardiac, renal, and hepatogenic edema.

Dosage form: tablets

ATC code: C03BA10

Manufacturer: Artesan Pharma GmbH & Co. KG

The drug is used to treat arterial hypertension (high blood pressure), as well as for edema caused by heart, kidney, or liver problems.

Dosage form: tablets

ATC code: C03BA10

Manufacturer: Artesan Pharma GmbH & Co. KG

The drug is used to treat arterial hypertension (high blood pressure), as well as cardiac, renal, and hepatogenic edema.

Dosage form: tablets

ATC code: C03BA10

Manufacturer: Artesan Pharma GmbH & Co. KG

The drug is used for the treatment of influenza in patients aged 12 years and older, as well as for the prevention of influenza after close contact with an infected person.

Dosage form: tablets, film-coated

ATC code: J05AX25

Manufacturer: F. Hoffmann-La Roche Ltd (batch release of finished medicinal product; quality control testing for release and stability (excluding microbiological purity); quality control testing for release and stability (only microbiological purity))

The drug is used for the treatment of influenza in patients aged 12 years and older, as well as for the prevention of influenza after close contact with an infected person.

Dosage form: tablets, film-coated

ATC code: J05AX25

Manufacturer: F. Hoffmann-La Roche Ltd (release of finished medicinal product; quality control testing upon release and stability (excluding microbiological purity), primary and secondary packaging, including in-process control, release of finished medicinal product; quality control testing upon release and stability (only microbiological purity))

The drug is used as add-on therapy to achieve better control in the following conditions: severe persistent allergic asthma (in adults and children from 6 years of age), chronic rhinosinusitis with nasal polyps (in adults), and chronic spontaneous urticaria (in adults and adolescents from 12 years of age).

Dosage form: powder for injection solution

ATC code: R03DX05

Manufacturer: Novartis Pharma Stein AG

The drug is used as add-on therapy for the treatment of severe allergic asthma (in adults and children from 6 years of age), chronic rhinosinusitis with nasal polyps (in adults), and chronic spontaneous urticaria (in adults and adolescents from 12 years of age).

Dosage form: powder for injection solution

ATC code: R03DX05

Manufacturer: Novartis Pharma Stein AG

The drug is used as add-on therapy for the treatment of severe allergic asthma (in adults and children from 6 years of age), chronic rhinosinusitis with nasal polyps (in adults), and chronic spontaneous urticaria (in adults and adolescents from 12 years of age).

Dosage form: solution for injection

ATC code: R03DX05

Manufacturer: Novartis Pharma GmbH (Batch release)